Muromachi Chemicals
4885.TPharmaceutical
Financials · Standalone
| Fiscal year ended | 2026-05 | 2025-05 | 2024-05 | 2023-05 | 2022-05 | 2021-05 |
|---|---|---|---|---|---|---|
| Revenue | ¥7.8bn | ¥6.7bn | ¥6.4bn | ¥6.3bn | ¥5.7bn | ¥4.9bn |
| Operating income | ¥743m | ¥432m | ¥422m | ¥369m | ¥437m | ¥369m |
| Ordinary income | ¥707m | ¥430m | ¥428m | ¥351m | ¥423m | ¥339m |
| Total assets | ¥6.4bn | ¥5.3bn | ¥5.1bn | ¥4.9bn | ¥4.8bn | ¥4.6bn |
| Net assets / equity | ¥2.6bn | ¥2.5bn | ¥2.3bn | ¥1.9bn | ¥1.7bn | ¥1.3bn |
| Operating cash flow | ¥808m | ¥216m | ¥638m | ¥317m | ¥525m | ¥488m |
| EPS (basic) | ¥40.58 | ¥60.42 | ¥83.42 | ¥67.94 | ¥123.79 | ¥65.24 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 13
| Period | Form | Figures |
|---|---|---|
| 2025-06-01 → 2026-05-31 | Annual | 129 figures · EDINET |
| 2025-06-01 → 2025-11-30 | Half-year | 75 figures · EDINET |
| 2024-06-01 → 2025-05-31 | Annual | 129 figures · EDINET |
| 2024-06-01 → 2024-11-30 | Half-year | 74 figures · EDINET |
| 2023-06-01 → 2024-05-31 | Annual | 132 figures · EDINET |
| 2023-06-01 → 2024-02-29 | Quarterly Q3 | 52 figures · EDINET |
| 2023-06-01 → 2023-11-30 | Quarterly Q2 | 76 figures · EDINET |
| 2023-06-01 → 2023-08-31 | Quarterly Q1 | 50 figures · EDINET |
| 2022-06-01 → 2023-05-31 | Annual | 141 figures · EDINET |
| 2022-06-01 → 2023-02-28 | Quarterly Q3 | 52 figures · EDINET |
| 2022-06-01 → 2022-11-30 | Quarterly Q2 | 76 figures · EDINET |
| 2022-06-01 → 2022-08-31 | Quarterly Q1 | 50 figures · EDINET |
| 2021-06-01 → 2022-05-31 | Annual | 135 figures · EDINET |
5 more reports are still being processed.